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Estimation of Candida albicans ABC
Transporter Behavior in Real-Time
via Fluorescence
Joanna Szczepaniak, Marcin Łukaszewicz and Anna Krasowska*
Faculty of Biotechnology, University of Wroclaw, Wroclaw, Poland
We present a fluorometric method for determining ABC transporter activity in the
pathogenic fungus C. albicans during different growth phases and in response to
glucose. The carbocyanine dye diS-C3(3) was previously used to monitor plasma
membrane potentials and test the influence of surface-active compounds in membrane
polarization. We used diS-C3(3) to show changes in fluorescence kinetics that
reflect changes in the activity of ABC transporters in C. albicans growth. Cdr1-GFP
fluorescence, revealed that Cdr1p relocates to the inside of the cell after the early-log
growth phase. Addition of glucose to the cell suspension resulted in Cdr1p transporter
expression in theCDR2-knockout strain. We confirmed the diS-C3(3) results by standard
RT-PCR and Western blotting.
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INTRODUCTION
Candida albicans normally occurs as a relatively harmless organism in the human microbiome
(Koh, 2013); however, C. albicans infection can be triggered by various perturbations in
homeostasis, such as compromised immune defense or breaks in the epithelium–blood barriers
due to injury or surgery. Interestingly, the risk of infection is also increased in diabetic patients
(Perlroth et al., 2007), possibly due to the dramatic eﬀects of glucose on C. albicans’ metabolism
(Brown et al., 2014) that increase virulence and drug resistance (Rodaki et al., 2009; Ene et al.,
2012; Mandal et al., 2014). Moreover, Mandal et al. (2014) found that glucose selectively interacts
with commonly used antifungal agents by forming complexes via hydrogen bonding, which, in
turn, lowers their eﬃcacy. The growing number of C. albicans strains resistant to pharmaceuticals
is decreasing the already low number of drugs available to treat candidiasis. Due to C. albicans’
multiple mechanisms to adapt to and resist drugs, new experimental approaches must be developed
to deﬁne the in vivo and/or real-time behaviors of individual cells (Brown et al., 2014). Many of
C. albicans’ adaptations and resistance mechanisms are related to the supramolecular structure
formed by the cell wall and plasma membrane. Active transport through the plasma membrane
is driven by transporters powered by high energy compounds, such as ATP, and/or membrane
potential (Cannon et al., 2009). Thus, it is very important to develop methods to directly monitor
drug transporters and plasma membrane-related activity in C. albicans.
Candida albicans’ drug transporters were previously investigated via heterologous expression in
Saccharomyces cerevisiae, but growing evidence indicates that C. albicans’ metabolism is diﬀerent
from that of S. cerevisiae, especially in terms of major transcriptional modiﬁcations and resistance
to osmotic stress and antifungal drugs (Garreau et al., 2000; Gasch et al., 2000; Ene et al., 2012;
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TABLE 1 | Candida albicans strains used in this study.
Strain Genotype Reference
CAF 2-1 ura3::imm434/URA3 Fonzi and Irwin, 1993
DSY 448 cdr1::hisG-URA3-hisG/cdr1::hisG Sanglard and Ischer, 1996
DSY 653 cdr2::hisG-URA3-hisG/cdr2::hisG Sanglard et al., 1997
DSY 654 cdr1::hisG/cdr1::hisG
cdr2::hisG-URA3-hisG/cdr2::hisG
Sanglard et al., 1997
DSY 4-2 ura3::imm434/ura3::imm434 Fonzi and Irwin, 1993
ASCa1 ura3::imm434/URA3 CDR1-GFP This study
Szczepaniak et al., 2015). Glucose, for example, enhances
oxidative stress resistance in C. albicans but decreases stress
resistance in S. cerevisiae (Garreau et al., 2000; Gasch et al., 2000).
Therefore, it is very important to account for many factors when
looking for new, eﬃcient treatment strategies of candidiasis.
We developed a ﬂuorescence method that allows in vivo real-
time monitoring of the activity of C. albicans’ drug eﬄux pumps,
Cdr1p, and Cdr2p, using a 3,3′-dipropylthiadicarbocyanine (diS-
C3(3)) probe (Szczepaniak et al., 2015). The method is based
on the property of diS-C3(3) to increase λmax after binding
to cell constituents (mostly proteins); since the maximum
ﬂuorescence wavelength of the bound probe is about 10 nm
higher than that of the free probe in solution, it allows us
to observe its accumulation in cells and thereby monitor the
actions of the probe-expelling pumps. This method also allows
us to examine membrane potential diﬀerences in S. cerevisiae
based on the changes of the ﬂuorescence spectra of diS-
C3(3) from equilibrium (Plášek et al., 2012). In this work,
we used diS-C3(3) to assess the scope of C. albicans ABC
transporter activity in response to membrane potential changes
and glucose.
MATERIALS AND METHODS
Strains and Growth Media
The C. albicans strains used in this study (Table 1) were generous
gifts from D. Sanglard (Lausanne, Switzerland). All strains were
grown at 28◦C on YPD medium with 2% glucose, 1% Bacto
peptone (Difco), and 1% yeast extract (Difco) with shaking at
120 rpm. Solid medium was supplemented with 2% agar.
Strain Construction
Strain ASCa1 was constructed by integration of the CDR1-GFP-
URA3 cassette into the chromosomal locus of CDR1 in the CAF
4-2 strain, as described by Gerami-Nejad et al. (2001). CDR1-
speciﬁc sequences were added to universal primers to generate
primers AS001 and AS003.We used primers AS003 and AS004 to
verify integration into the chromosomal locus of CDR1 (Table 2).
Sample Preparation
Cells were prepared according to the method of Gásková et al.
(1998), with modiﬁcations. One hundred and ﬁfty microliter of
overnight, stationary culture were added to 20 ml of fresh YPD
medium and incubated at 28◦C with shaking at 120 rpm for
TABLE 2 | Primers used in this study.
Primer name Sequence Reference
AS001 CATTCTTACGGTGATCTTTTATTGGT
TAGCCAGAGAGAATAGAGTTCCAAAG
GGTAAAAAAAATAAGAAAGGTGGT
GGTTCTAAAGGTGAAGAATTATT
Larsen et al., 2006
AS002 ACAACAACAATAGTCTAAAAACGTC
TATTATATTTTAGACGTTTGAGATACC
ACCATGTCAAAAAACAAATCTAGAAG
GACCACCTTTGATTG
AS003 ACATTAAATTTGCTGGTGGG This study
AS004 CCTTCTGGCATGGCAGACTTG
ACT1-F TTTAAGAATTGATTTGGCT Murzyn et al., 2010
ACT1-R GAAGATTGAGAAGAAGTTT
CDR1-F TGCCAAACAATCCAACAA Ricardo et al., 2009
CDR1-R CGACGGATCACCTTTCATACGA
10, 14, or 24 h. The cells were then harvested by centrifuging
at 110 × g for 3 min, washing twice with deionised water,
and resuspending in citrate-phosphate (CP) buﬀer (pH 6.0) at
OD600 = 0.1.
DiS-C3(3) Uptake into Cells
Samples (3 ml, OD600 = 0.1) were labeled with diS-C3(3)
at a ﬁnal concentration of 5×10−8 M at room temperature.
Fluorescence spectra were measured every 4 min for 120 min,
with gentle stirring before each measurement, on a Fluorescence
Spectrophotometer (HITACHI F-4500) equipped with a xenon
lamp. The excitation wavelength was 531 nm and the ﬂuorescence
range was 560–590 nm. Scattered light was eliminated by an
amber glass ﬁlter with a cut-oﬀ wavelength of 540 nm. If
indicated, glucose was added at a ﬁnal concentration of 2%.
Microscopy Studies
Strains were grown for 24 h in YPDmedium at 28◦Cwith shaking
at 120 rpm. At indicated times, aliquots of cell culture were
pelleted by centrifuging, washed in deionised water, and 4 μl of
samples were visualized with a ZEISS AXIO IMAGER.A2.
Real-time PCR
The assay was prepared from samples (5 ml, OD600 = 0.4)
after staining with 2×10−7 M diS-C3(3) probe for 40, 72, or
96 min, with 2% glucose added after 60 min if indicated.
Aliquots of cell suspensions were pelleted by centrifuging at
2260 × g for 5 min. Cells were resuspended in lysis buﬀer
(1 M sorbitol, 0.1 M EDTA, 1% β-mercaptoethanol, 2.5 mg/ml
zymolyase), incubated at 37◦C for 30 min, and centrifuged
at 2834 × g. Total RNA was extracted using a Total RNA
Mini kit (A&A Biotechnology) according to the manufacturer’s
instructions. The purity and concentration of RNA samples were
determined from A260/A280 readings and RNA integrity was
checked by electrophoresis. Samples were treated with DNAse I
(Fermentas) to remove genomic DNA contamination. The cDNA
was synthesized using 0.5 μg RNA with a High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Real-time PCR
reactions with performed with a DyNAmo HS SYBR Green
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qPCR Kit (Thermo Scientiﬁc) and a 7500 Real-Time PCR System
(Applied Biosystems). Gene-speciﬁc primers for actin (ACT1-F
and ACT1-R) and CDR1 (CDR1-F and CDR1-R) were used. The
thermal cycling conditions consisted of the initial step at 50◦C
for 2 min, then 95◦C for 10 min, followed by 35 cycles at 95◦C
for 20 s, 45◦C for 20 s, and 72◦C for 30 s. The gene expression
level of the wild-type strain at 40 min of incubation, relative to
that of the other time points, was calculated using the formula
2−CT.
Western Blotting
The assay was performed according to the method of Hiller
et al. (2006), with modiﬁcations. Crude protein extract was
prepared from samples (5 ml, OD600 = 0.4) after staining
with 2×10−7 M diS-C3(3) probe for 10, 40, 72, or 96 min,
with 2% glucose added after 60 min if indicated. Aliquots of
cell suspensions were pelleted by centrifuging at 2260 × g
for 5 min and resuspended in 1 ml of deionised water. Cells
were lysed by the addition of 150 μl of 1.85 M NaOH-
7.5% β-mercaptoethanol and incubated on ice for 10 min.
Proteins were precipitated by the addition of 150 μl of 50%
trichloroacetic acid and incubated on ice for 10 min. Samples
were then centrifuged at 10,000 × g for 5 min at 4◦C, washed
in 1 ml of 1 M Tris-HCl (pH 8.0), and resuspended in 20 μl
sample buﬀer (40 mM Tris-HCl, 8 M urea, 5% SDS, 0.1 mM
EDTA, 1% β-mercaptoethanol, 0.1 mg/ml bromophenol blue),
followed by incubation at 37◦C for 30 min. Five microliter of
protein extract were loaded in a 10% sodium dodecyl sulfate-
polyacrylamide gel and electrophoresed in a Mini-PROTEAN
II electrophoresis cell (Bio-Rad). After the electrophoresis, the
samples were transferred onto a nitrocellulose membrane using
a Mini-PROTEAN Tetra System electrophoresis cell (Bio-Rad).
The membranes were stained with Ponceau S to check for
equal loading of the gels. Immunodetection of Cdr1p was
performed using a polyclonal rabbit anti-Cdr1p antiserum
(a generous gift from D. Sanglard, Lausanne, Switzerland)
and horseradish peroxidase-conjugated anti-rabbit antiserum
as a secondary antibody. Signals were detected using an
ECL kit from PerkinElmer according to the manufacturer’s
instructions.
RESULTS AND DISCUSSION
Membrane Potential, as Measured by
diS-C3(3) Fluorescence, is a Factor in
ABC Transporter Activity During Phases
of C. albicans Growth
As indicated by Plášek et al. (2012) and Plášek and Gášková
(2013), diS-C3(3) is a suitable probe to monitor real-time
changes in plasma membrane potential; here, we are the ﬁrst
to describe this use in C. albicans. To monitor the changes
we measured the ﬂuorescence λmax in the strain without ABC
transporters to remove their eﬀect on probe eﬄux. Probe
accumulation took only 30 min in the early log-phase but
took 60 and 50 min, respectively, to accumulate after 14 and
24 h in culture (Figure 1). As cultures age, the cells and
the structure and function of their membranes change. The
kinetics of diS-C3(3) ﬂuorescence (Figure 1) reﬂect changes
in the membrane potential of cells in diﬀerent phases of
growth. An age-induced reduction in membrane potential
correlates with decreased polarization (Kumar et al., 2015).
Cell membrane depolarisation can cause lateral redistribution
of membrane proteins (Grossmann et al., 2007). Kumar
et al. (2015) found that membrane ﬂuidity contributes to
drug diﬀusion and resistance. Higher membrane ﬂuidity can
lead to incorrect localization of the Cdr1p pump and thus
lack of Cdr1p activity. The C. albicans strain with CDR1
overexpression and drug resistance had a more rigid membrane
than the drug-sensitive strain; this rigidity increased until the
late-log phase of growth. On the other hand, the wild-type
C. albicans SC5314 increased the ﬂuidity of its membrane
during growth. In the C. albicans mutants with deletion
of a key component required during the biogenesis of
mitochondria, decreases in the cellular ergosterol level and
mis-sorting of Cdr1p into vacuoles were observed (Thomas
et al., 2013). Similar eﬀects were observed in the S. cerevisiae
strain expressing C. albicans CDR1 with deletions in the
genes involved in ergosterol synthesis (Pasrija et al., 2008).
Mukhopadhyay et al. (2004) found that Cdr1p dislocated
from the cell membrane after incubating Saccharomyces cells
FIGURE 1 | DiS-C3(3) fluorescence staining of wild-type and CDR1 CDR2 strains during early log-phase (A), late log-phase (B), and stationary
phase (C). 2% glucose was added at the start of the experiment (n = 3). Pictures: Cdr1-GFP localization during (A–C).
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FIGURE 2 | DiS-C3(3) fluorescence staining of wild-type (A) and CDR2 (B) strains during early log-phase. Glucose was added after 60 min of staining.
(C) Expression of CDR1 during the experiment. Samples were taken at 40, 72, or 96 min from the beginning of the experiment. (D) Cdr1 protein levels during the
experiment. Samples were taken at 40, 72, or 96 min from the beginning of the experiment (n = 3).
with ﬁlipin, which interacts with the 3-hydroxyl group of
membrane sterols. In this study, we observe that the Cdr1p
pump fused with GFP is located in the plasma membrane in
the early logarithmic phase (Figure 1A). Starting from the 14 h
late log-phase, the movement of Cdr1p from the membrane
to inside the cells becomes noticeable; strong ﬂuorescence
can be observed there in the stationary phase of growth
(Figures 1B,C), although we do not see drop in pumps
activity.
Glucose Causes de Novo Synthesis of
Cdr1p in CDR2
The most important factor in the activity of ABC transporters is
ATP energy. C. albicans is a Crabtree-negative yeast and retains
respiratory activity during growth at high glucose concentrations.
Cdr1p and Cdr2p are up-regulated in the presence of glucose and
this process probably increases resistance to azoles (Rodaki et al.,
2009). To see if diS-C3(3) export can be facilitated by glucose
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we added it at the beginning of the experiment. In the early
log-phase of growth (Figure 1A) glucose promotes dye eﬄux
but this eﬀect fades in further stages of culture (14 h late-log
and 24 h stationary phase; Figures 1B,C). Interestingly the most
marked change could be observed in cdr2 strain (Figure 2B).
In the experiment without glucose CDR1 pump was inactive
(Figure 2B) and the diﬀerence in λmax between it and after the
addition of glucose was more pronounced than in the strain
with both pumps (Figures 2A,B). This fact indicates that Cdr2p
actively participates in removing diS-C3(3) from the fungal cells.
We used standard molecular methods to assess if the increased
activity of Cdr1 under the inﬂuence of glucose was due to pump
activation or pump overexpression. As shown in Figure 2D,
western blot showed high levels of Cdr1 protein after induction
of glucose in a strain lacking Cdr2p, whereas Cdr1p was observed
at very low levels in control conditions (Figure 2D). In contrast,
in the wild-type strain, Cdr1p was detected after 72 min but
the level of this protein appeared to be the same, regardless of
whether glucose was added (Figure 2D); this was reﬂected in both
strains’ diS-C3(3) eﬄux. As shown in Figure 2C, cdr2 expresses
CDR1 continuously at a very low level. Glucose addition in
cdr2 causes a twofold increase in CDR1 expression after 12 min
and fourfold increase after 36 min. Interestingly, under the
same conditions in the wild-type strain, CDR1 transcript level
change is not detectable at 12 min after addition of glucose; after
36 min we observe a ﬁvefold increase in transcript which do
not correlate with protein level at this time point. This delayed
response of wild-type strain to glucose may be a natural lag
in between the gene expression and protein levels. Although
cdr2 faster reaction could be a result of this strain need to
complement deleted CDR2. Both gene expression and Western
blotting suggested that glucose caused de novo synthesis of the
Cdr1 pump in C. albicans cdr2.
ABC transporter upregulation in C. albicans can be caused by
antifungal drugs (Henry et al., 1999; Coste et al., 2004; Schneider
and Morschhäuser, 2015), antibiotics (Vogel et al., 2008), or
human steroid hormones (Larsen et al., 2006; Banerjee et al.,
2007). C. albicans is a human pathogen; environmental glucose
may be another sign that yeast cells have entered the bloodstream
and to adapt express a virulence phenotype. One of the virulence
factors of C. albicans, its ability to form hyphal forms, can be
triggered by addition of serum to cultures at 37◦C (Hudson et al.,
2004). The active component starting this process is glucose;
changes in C. albicans transcriptome, including CDR1 and CDR2
(Rodaki et al., 2009), start as early as 30 min after the addition
of no more than 0.01% glucose – a concentration much lower
than that in human serum (0.06–0.1%). Our results using diS-
C3(3) also suggest that activation of Cdr1p under the inﬂuence of
glucose results in overexpression of this pump, especially in case
where CDR2 is deleted.
CONCLUSION
In this study, we showed that the diS-C3(3) carbocyanine probe
can be used as a multipurpose ﬂuorescent assay.
• DiS-C3(3) can be used to assess both membrane polarization
and ABC transporter activity in C. albicans.
• Increase of the export diS-C3(3) by glucose depends on growth
phase and is the strongest at the beginning of the log-phase.
• In case of cdr2 strain observed increase in diS-C3(3) export
is caused de novo synthesis of Cdr1p.
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